AllSight
Companies · PRGO · Pharmaceutical Preparations

PERRIGO Co plc (PRGO)

PERRIGO Co plc (PRGO) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

PERRIGO Co plc (PRGO) stock — financials & valuation

Key numbers for PERRIGO Co plc (PRGO): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 34/100 — a percentile rank of PERRIGO Co plc’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$1.9B
P / S0.5×
EV / EBITDA8.1×
Gross margin33.3%
Operating margin-37.7%
Net margin-41.8%
Return on equity-69.0%
ROIC-30.5%
Revenue growth-4.2%
Debt / equity1.3×
Dividend yield8.2%

Is PERRIGO Co plc overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from PERRIGO Co plc’s own financial statements and shown as context, never as advice.

Aug 5, 2026
Earnings beat estimates, but core sales and margins still retreated.
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact